Cleared Special

K211991 - Catalyst R1 Reverse Shoulder System (FDA 510(k) Clearance)

Jul 2021
Decision
30d
Days
Class 2
Risk

K211991 is an FDA 510(k) clearance for the Catalyst R1 Reverse Shoulder System. This device is classified as a Shoulder Prosthesis, Reverse Configuration (Class II - Special Controls, product code PHX).

Submitted by Catalyst Orthoscience, Inc. (Naples, US). The FDA issued a Cleared decision on July 28, 2021, 30 days after receiving the submission on June 28, 2021.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3660. Intended To Be Used To Relieve Pain And To Replace The Glenoid And Humeral Side Of The Shoulder Joint In Order To Restore Mobility In A Grossly Rotator Cuff Deficient Joint With Severe Arthropathy Or A Previous Joint Replacement With A Grossly Rotator Cuff Deficient Joint..

Submission Details

510(k) Number K211991 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 28, 2021
Decision Date July 28, 2021
Days to Decision 30 days
Submission Type Special
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code PHX - Shoulder Prosthesis, Reverse Configuration
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3660
Definition Intended To Be Used To Relieve Pain And To Replace The Glenoid And Humeral Side Of The Shoulder Joint In Order To Restore Mobility In A Grossly Rotator Cuff Deficient Joint With Severe Arthropathy Or A Previous Joint Replacement With A Grossly Rotator Cuff Deficient Joint.